AnnouncementsGlenmark Pharmaceuticals: Outcome of board meeting
AnnouncementsGlenmark Pharmaceuticals: Q2 results on Oct 31, 2013
|Company Name||Last Price||%
|Dr Reddys Labs||2421.95||0.00||2545.00||1764.00||41,197.31|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
Glenmark is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 14,236.77 crore.The company has reported a consolidated sales of Rs 1463.38 crore and a Net Profit of Rs 157.3 crore for the quarter ended Sep 2013.
The company management includes Glenn Saldanha - Chairman & Managing Director, Rajesh V Desai - Executive Director & CFO, Cherylann Pinto - Director - Corporate Affairs, D R Mehta - Non Executive Director, Bernard Munos - Non Executive Director, J F Ribeiro - Non Executive Director, Brian W Tempest - Non Executive Director, Sridhar Gorthi - Non Executive Director, Hocine Sidi Said - Non Executive Director, N B Desai - Non Executive Director.
It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.
Its Registered office is at B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai,Maharashtra - 400026.
Their Registrars are Karvy Computershare Private Ltd.